NCT00883688 2020-08-26
Bevacizumab and Lapatinib in Children With Recurrent or Refractory Ependymoma
M.D. Anderson Cancer Center
Phase 2 Completed
M.D. Anderson Cancer Center
Hellenic Cooperative Oncology Group
Dana-Farber Cancer Institute
Case Comprehensive Cancer Center
UNICANCER
Jules Bordet Institute